AU2002222931A1 - Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a - Google Patents
Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin aInfo
- Publication number
- AU2002222931A1 AU2002222931A1 AU2002222931A AU2293102A AU2002222931A1 AU 2002222931 A1 AU2002222931 A1 AU 2002222931A1 AU 2002222931 A AU2002222931 A AU 2002222931A AU 2293102 A AU2293102 A AU 2293102A AU 2002222931 A1 AU2002222931 A1 AU 2002222931A1
- Authority
- AU
- Australia
- Prior art keywords
- curacin
- antimitotic
- analogs
- synthesis
- natural product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21928300P | 2000-07-19 | 2000-07-19 | |
US60/219,283 | 2000-07-19 | ||
US24618600P | 2000-11-16 | 2000-11-16 | |
US60/246,186 | 2000-11-16 | ||
PCT/US2001/022698 WO2002006267A2 (en) | 2000-07-19 | 2001-07-19 | Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002222931A1 true AU2002222931A1 (en) | 2002-01-30 |
Family
ID=26913745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002222931A Abandoned AU2002222931A1 (en) | 2000-07-19 | 2001-07-19 | Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a |
Country Status (3)
Country | Link |
---|---|
US (1) | US6392055B1 (en) |
AU (1) | AU2002222931A1 (en) |
WO (1) | WO2002006267A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9353150B2 (en) | 2012-12-04 | 2016-05-31 | Massachusetts Institute Of Technology | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment |
US10201623B2 (en) | 2013-03-15 | 2019-02-12 | Memorial Sloan Kettering Cancer Center | HSP90-targeted cardiac imaging and therapy |
CN103833691A (en) * | 2014-03-17 | 2014-06-04 | 上海应用技术学院 | Preparation method of 5-(3,3-dimethylethylene oxide-2-yl)-3-methyl-2-pentenyl acetate |
US10918627B2 (en) | 2016-05-11 | 2021-02-16 | Massachusetts Institute Of Technology | Convergent and enantioselective total synthesis of Communesin analogs |
WO2018209239A1 (en) | 2017-05-11 | 2018-11-15 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
US11535634B2 (en) | 2019-06-05 | 2022-12-27 | Massachusetts Institute Of Technology | Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof |
WO2022182415A1 (en) | 2021-02-24 | 2022-09-01 | Massachusetts Institute Of Technology | Himastatin derivatives, and processes of preparation thereof, and uses thereof |
CN115850224B (en) * | 2022-07-22 | 2024-07-19 | 北京先通国际医药科技股份有限公司 | Synthesis method and application of modified long-chain fatty acid type PET reagent precursor |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5324739A (en) | 1993-10-07 | 1994-06-28 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Compound exhibiting antiproliferative activity against cells |
AU7964894A (en) * | 1993-10-07 | 1995-05-01 | State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University, The | Compounds exhibiting antiproliferative activity against cells |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US5919815A (en) | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
US5886025A (en) * | 1997-03-06 | 1999-03-23 | Baylor University | Anti-mitotic agents which inhibit tubulin polymerization |
US6057348A (en) * | 1997-07-14 | 2000-05-02 | Oregon State University | Curacin A analogs exhibiting antiproliferative activity against cells |
-
2001
- 2001-07-19 AU AU2002222931A patent/AU2002222931A1/en not_active Abandoned
- 2001-07-19 WO PCT/US2001/022698 patent/WO2002006267A2/en active Application Filing
- 2001-07-19 US US09/909,076 patent/US6392055B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2002006267A2 (en) | 2002-01-24 |
WO2002006267A3 (en) | 2003-01-30 |
US6392055B1 (en) | 2002-05-21 |
US20020037918A1 (en) | 2002-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL137293A0 (en) | Carotenoid-bearing lipids from a marine source and pharmaceutical compositions containing the same | |
EG24138A (en) | Asymmetrics synthesis of pregabalin | |
AU2002237676A1 (en) | Methods and materials for the synthesis of organic products | |
AU2002213248A1 (en) | Synthesis of epothilones and relates analogs | |
AU2001283202A1 (en) | User-directed product recommendations | |
AU2002212193A1 (en) | Printed flexible packing material | |
AU2001243323A1 (en) | Synthesis of alkylbenzenes and synlubes from fischer-tropsch products | |
AU5044899A (en) | Fluid product sample | |
AU2002228623A1 (en) | A distributed-service architecture at the point of sale or service | |
AU3362999A (en) | Halimide, a cytotoxic marine natural product, and derivatives thereof | |
AU4064599A (en) | A vessel of the obo or bulk carrier type | |
AU2002222931A1 (en) | Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a | |
AU2001235699A1 (en) | Cosmetic or dermopharmaceutical compositions containing the val-trp dipeptide | |
AU2002338831A1 (en) | Method for the production of a flexible bulk-material container and bulk-material container produced according to said method | |
AU2001231125A1 (en) | Flexible multi-layer gasketing product | |
AU7727700A (en) | Robust process for the synthesis of polyestercarbonates | |
AU5702099A (en) | A novel protein related to melanoma-inhibiting protein and uses thereof | |
AUPR197000A0 (en) | Synthesis of small particles | |
GB2325385B (en) | High pressure fish container | |
AU4632399A (en) | Ester synthesis | |
AU6256599A (en) | Flexible disposable container | |
AU2001243435A1 (en) | Intermediates useful for the synthesis of huperzine a | |
AU2000222749A1 (en) | Mechanically regulated time indicator | |
AU2001250635A1 (en) | Improved composition of marine product | |
AU1789799A (en) | Arrangement of a ship's construction |